| |
| |
|
| Insider
Information: |
Greenway Schond L. |
| Relationship: |
|
| City: |
Rockville |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
214,940 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,793,544 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
214,940 |
|
|
| Total
Value |
$1,793,544 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Avalo Therapeutics, Inc |
AVTX |
CFO |
2021-12-10 |
3,883 |
|
0 |
Premium* |
|
|
Mind Medicine |
MNMD |
|
2024-03-25 |
211,057 |
2022-05-23 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MNMD |
Mind Medicine |
Chief Financial Officer |
• – – |
2024-03-25 |
4 |
D |
$9.78 |
$54,377 |
D/D |
(5,560) |
211,057 |
0 |
- |
|
| MNMD |
Mind Medicine |
Chief Financial Officer |
• – – |
2023-12-26 |
4 |
S |
$3.63 |
$20,517 |
D/D |
(5,652) |
216,617 |
0 |
% |
|
| MNMD |
Mind Medicine |
Chief Financial Officer |
• – – |
2023-09-25 |
4 |
S |
$3.57 |
$20,609 |
D/D |
(5,762) |
222,269 |
0 |
% |
|
| MNMD |
Mind Medicine |
Chief Financial Officer |
• – – |
2023-08-25 |
4 |
S |
$3.80 |
$76,000 |
D/D |
(20,000) |
228,031 |
0 |
% |
|
| MNMD |
Mind Medicine |
Chief Financial Officer |
• – – |
2023-06-27 |
4 |
S |
$3.19 |
$37,194 |
D/D |
(11,635) |
248,031 |
0 |
% |
|
| MNMD |
Mind Medicine |
Chief Financial Officer |
• – – |
2023-03-14 |
4/A |
A |
$0.00 |
$0 |
D/D |
175,000 |
259,666 |
0 |
- |
|
| MNMD |
Mind Medicine |
Chief Financial Officer |
• – – |
2023-03-14 |
4 |
A |
$0.00 |
$0 |
D/D |
175,000 |
1,445,000 |
0 |
- |
|
| MNMD |
Mind Medicine |
Chief Financial Officer |
• – – |
2022-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
1,270,000 |
1,270,000 |
0 |
- |
|
| AVTX |
Avalo Therapeutics, Inc |
CFO |
• – – |
2021-12-10 |
4 |
B |
$1.57 |
$3,503 |
D/D |
2,231 |
3,883 |
2.66 |
% |
|
| AVTX |
Avalo Therapeutics, Inc |
CFO |
• – – |
2021-06-10 |
4 |
B |
$2.68 |
$1,747 |
D/D |
652 |
1,652 |
2.66 |
% |
|
| AVTX |
Avalo Therapeutics, Inc |
CFO & TreasurerOfficer |
• – – |
2021-03-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,000 |
|
% |
|
11 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
